NTBL
Get informed when a big investor buys or sells
+ FollowOvervalued by 111.7% based on the discounted cash flow analysis.
| Market cap | $2.39 Million |
|---|---|
| Enterprise Value | $97,590.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.03 |
| Beta | -2.36 |
| Outstanding Shares | 9,455,751 |
| P/E Ratio | -0.05 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 32.53 |
| Enterprise Value to EBIT | -0.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 18.39 |
| Debt to Equity | 0.25 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
vascular biogenics ltd. is a biotechnology company located in 6yonatan netanyahu street, yehud, center district, israel.